Chemotherapy Induced Anemia

2

Review clinical trials related to Chemotherapy Induced Anemia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Study of AND017 in Cancer Related Anemic Patients Receiving Chemotherapy

The purpose of this study is to determine the safety and efficacy of AND017 after 6 weeks of treatment in patients with cancer-related anemia who are receiving chemotherapy.

Participants needed: 36
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Kind Pharmaceuticals LLCUpdated: Feb 27, 2026
Eligibility criteria

Non-myeloid malignancy diagnosed by cytology/histology [+8]

Hematocrit (Hct) ≥ 36 vol% at the screening assessment. [+15]

Status: Not yet recruiting

Study of SSS06 for Chemotherapy-Induced Anemia in Non-Myeloid Malignancies

This study employs a multicenter, randomized, open-label, positive drug-controlled, multiple ascending dose clinical trial design to comprehensively evaluate the safety, tolerability, immunogenicity, and pharmacokinetic characteristics of SSS06 injection in patients with chemotherapy-induced anemia from non-myeloid malignancies, while also exploring its potential efficacy.

Participants needed: 80
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Shenyang Sunshine Pharmaceutical Co., LTD.Updated: Mar 3, 2025
Eligibility criteria

Male or female participants aged ≥18 years at the time of signing the informed c... [+9]

Patients undergoing myelosuppressive chemotherapy with an expected curative outc... [+20]